title: Bioactive compounds: safety and efficacy.
abstract: The efficacy and safety of bioactive compounds depend on a few known and unknown parameters. What is a physiologic dose and how can that dose be defined in cases of bioactive compounds with a poor knowledge of supply and distribution? What safety sets are needed? How can individual aspects such as polymorphisms or differences in absorption be considered? A group of experts tried to answer these and related questions during the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart.
authors: Department of Biological Chemistry and Nutrition, University of Hohenheim, Stuttgart, Germany. biesal@uni-hohenheim.de
authors: Hans-Konrad
authors: HK
authors: Biesalski
authors: Lars Ove
authors: LO
authors: Dragsted
authors: Ibrahim
authors: I
authors: Elmadfa
authors: Rolf
authors: R
authors: Grossklaus
authors: Michael
authors: M
authors: Müller
authors: Dieter
authors: D
authors: Schrenk
authors: Paul
authors: P
authors: Walter
authors: Peter
authors: P
authors: Weber
mesh_terms: D001688:Biological Products / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D019587:Dietary Supplements; D054796:Drug Dosage Calculations; D006801:Humans; D007408:Intestinal Absorption; D011110:Polymorphism, Genetic
chemical_list: D001688:Biological Products; D015415:Biomarkers